FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α-synuclein expression

Christian Wider, Justus C. Dachsel, Alexandra I. Soto, Michael G. Heckman, Nancy N. Diehl, Mei Yue, Sarah Lincoln, Jan O. Aasly, Kristoffer Haugarvoll, John Q. Trojanowski, Spiridon Papapetropoulos, Deborah C Mash, Alex Rajput, Ali H. Rajput, J. Mark Gibson, Timothy Lynch, Dennis W. Dickson, Ryan J. Uitti, Zbigniew K. Wszolek, Matthew J. FarrerOwen A. Ross

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Genetic variation in fibroblast growth factor 20 (FGF20) has been associated with risk of Parkinson's disease (PD). Functional evidence suggested the T allele of one SNP, rs12720208 C/T, altered PD risk by increasing FGF20 and α-synuclein protein levels. Herein we report our association study of FGF20 and PD risk in four patient-control series (total: 1,262 patients and 1,881 controls), and measurements of FGF20 and a-synuclein protein levels in brain samples (nine patients). We found no evidence of association between FGF20 variability and PD risk, and no relationship between the rs12720208 genotype, FGF20 and α-synuclein protein levels.

Original languageEnglish
Pages (from-to)455-459
Number of pages5
JournalMovement Disorders
Volume24
Issue number3
DOIs
StatePublished - Feb 15 2009

Fingerprint

Synucleins
Fibroblast Growth Factors
Parkinson Disease
Virulence
Proteins
Single Nucleotide Polymorphism
Alleles
Genotype
Brain

Keywords

  • α-Synuclein
  • Association study
  • FGF20
  • Genetics
  • Parkinson's disease

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

Wider, C., Dachsel, J. C., Soto, A. I., Heckman, M. G., Diehl, N. N., Yue, M., ... Ross, O. A. (2009). FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α-synuclein expression. Movement Disorders, 24(3), 455-459. https://doi.org/10.1002/mds.22442

FGF20 and Parkinson's disease : No evidence of association or pathogenicity via α-synuclein expression. / Wider, Christian; Dachsel, Justus C.; Soto, Alexandra I.; Heckman, Michael G.; Diehl, Nancy N.; Yue, Mei; Lincoln, Sarah; Aasly, Jan O.; Haugarvoll, Kristoffer; Trojanowski, John Q.; Papapetropoulos, Spiridon; Mash, Deborah C; Rajput, Alex; Rajput, Ali H.; Gibson, J. Mark; Lynch, Timothy; Dickson, Dennis W.; Uitti, Ryan J.; Wszolek, Zbigniew K.; Farrer, Matthew J.; Ross, Owen A.

In: Movement Disorders, Vol. 24, No. 3, 15.02.2009, p. 455-459.

Research output: Contribution to journalArticle

Wider, C, Dachsel, JC, Soto, AI, Heckman, MG, Diehl, NN, Yue, M, Lincoln, S, Aasly, JO, Haugarvoll, K, Trojanowski, JQ, Papapetropoulos, S, Mash, DC, Rajput, A, Rajput, AH, Gibson, JM, Lynch, T, Dickson, DW, Uitti, RJ, Wszolek, ZK, Farrer, MJ & Ross, OA 2009, 'FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α-synuclein expression', Movement Disorders, vol. 24, no. 3, pp. 455-459. https://doi.org/10.1002/mds.22442
Wider, Christian ; Dachsel, Justus C. ; Soto, Alexandra I. ; Heckman, Michael G. ; Diehl, Nancy N. ; Yue, Mei ; Lincoln, Sarah ; Aasly, Jan O. ; Haugarvoll, Kristoffer ; Trojanowski, John Q. ; Papapetropoulos, Spiridon ; Mash, Deborah C ; Rajput, Alex ; Rajput, Ali H. ; Gibson, J. Mark ; Lynch, Timothy ; Dickson, Dennis W. ; Uitti, Ryan J. ; Wszolek, Zbigniew K. ; Farrer, Matthew J. ; Ross, Owen A. / FGF20 and Parkinson's disease : No evidence of association or pathogenicity via α-synuclein expression. In: Movement Disorders. 2009 ; Vol. 24, No. 3. pp. 455-459.
@article{2279bbe3d298465db4af5f74d59b0a10,
title = "FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α-synuclein expression",
abstract = "Genetic variation in fibroblast growth factor 20 (FGF20) has been associated with risk of Parkinson's disease (PD). Functional evidence suggested the T allele of one SNP, rs12720208 C/T, altered PD risk by increasing FGF20 and α-synuclein protein levels. Herein we report our association study of FGF20 and PD risk in four patient-control series (total: 1,262 patients and 1,881 controls), and measurements of FGF20 and a-synuclein protein levels in brain samples (nine patients). We found no evidence of association between FGF20 variability and PD risk, and no relationship between the rs12720208 genotype, FGF20 and α-synuclein protein levels.",
keywords = "α-Synuclein, Association study, FGF20, Genetics, Parkinson's disease",
author = "Christian Wider and Dachsel, {Justus C.} and Soto, {Alexandra I.} and Heckman, {Michael G.} and Diehl, {Nancy N.} and Mei Yue and Sarah Lincoln and Aasly, {Jan O.} and Kristoffer Haugarvoll and Trojanowski, {John Q.} and Spiridon Papapetropoulos and Mash, {Deborah C} and Alex Rajput and Rajput, {Ali H.} and Gibson, {J. Mark} and Timothy Lynch and Dickson, {Dennis W.} and Uitti, {Ryan J.} and Wszolek, {Zbigniew K.} and Farrer, {Matthew J.} and Ross, {Owen A.}",
year = "2009",
month = "2",
day = "15",
doi = "10.1002/mds.22442",
language = "English",
volume = "24",
pages = "455--459",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - FGF20 and Parkinson's disease

T2 - No evidence of association or pathogenicity via α-synuclein expression

AU - Wider, Christian

AU - Dachsel, Justus C.

AU - Soto, Alexandra I.

AU - Heckman, Michael G.

AU - Diehl, Nancy N.

AU - Yue, Mei

AU - Lincoln, Sarah

AU - Aasly, Jan O.

AU - Haugarvoll, Kristoffer

AU - Trojanowski, John Q.

AU - Papapetropoulos, Spiridon

AU - Mash, Deborah C

AU - Rajput, Alex

AU - Rajput, Ali H.

AU - Gibson, J. Mark

AU - Lynch, Timothy

AU - Dickson, Dennis W.

AU - Uitti, Ryan J.

AU - Wszolek, Zbigniew K.

AU - Farrer, Matthew J.

AU - Ross, Owen A.

PY - 2009/2/15

Y1 - 2009/2/15

N2 - Genetic variation in fibroblast growth factor 20 (FGF20) has been associated with risk of Parkinson's disease (PD). Functional evidence suggested the T allele of one SNP, rs12720208 C/T, altered PD risk by increasing FGF20 and α-synuclein protein levels. Herein we report our association study of FGF20 and PD risk in four patient-control series (total: 1,262 patients and 1,881 controls), and measurements of FGF20 and a-synuclein protein levels in brain samples (nine patients). We found no evidence of association between FGF20 variability and PD risk, and no relationship between the rs12720208 genotype, FGF20 and α-synuclein protein levels.

AB - Genetic variation in fibroblast growth factor 20 (FGF20) has been associated with risk of Parkinson's disease (PD). Functional evidence suggested the T allele of one SNP, rs12720208 C/T, altered PD risk by increasing FGF20 and α-synuclein protein levels. Herein we report our association study of FGF20 and PD risk in four patient-control series (total: 1,262 patients and 1,881 controls), and measurements of FGF20 and a-synuclein protein levels in brain samples (nine patients). We found no evidence of association between FGF20 variability and PD risk, and no relationship between the rs12720208 genotype, FGF20 and α-synuclein protein levels.

KW - α-Synuclein

KW - Association study

KW - FGF20

KW - Genetics

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=67651120265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651120265&partnerID=8YFLogxK

U2 - 10.1002/mds.22442

DO - 10.1002/mds.22442

M3 - Article

C2 - 19133659

AN - SCOPUS:67651120265

VL - 24

SP - 455

EP - 459

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 3

ER -